XML 23 R14.htm IDEA: XBRL DOCUMENT v3.21.4
Equity Compensation Plans
6 Months Ended
Nov. 30, 2021
Equity Compensation Plans
7. EQUITY COMPENSATION PLANS
Incentive and
non-qualified
options to purchase shares of common stock have been granted to directors, officers and employees of Neogen under the terms of the Company’s stock option plans. These options are granted at an exercise price of not less than the fair market value of the stock on the date of grant. Options vest ratably over three and five year periods and the contractual terms are generally five or ten years. A summary of stock option activity during the six months ended November 30, 2021 follows:
 
           
Weighted-
 
           
Average
 
(Options in thousands)
  
Shares
    
Exercise Price
 
Options outstanding June 1, 2021
     2,957      $ 30.38  
Granted
     392        40.93  
Exercised
     (262      22.42  
Forfeited
     (21      31.11  
    
 
 
          
Options outstanding November 30, 2021
     3,066      $ 32.40  
During the three and six month periods ended November 30, 2021 and 2020, the Company recorded $1,748,000 and $1,511,000 and $3,438,000 and $3,192,000, respectively, of compensation expense related to its share-based awards.
The weighted-average fair value per share of stock options granted during the first six months of fiscal years 2022 and 2021, estimated on the date of grant using the Black-Scholes option pricing model, was $9.54 and $7.71, respectively. The fair value of stock options granted was estimated using the following weighted-average assumptions.
 
    
FY 2022
   
FY 2021
 
Risk-free interest rate
     0.4     0.2
Expected dividend yield
     0.0     0.0
Expected stock price volatility
     32.8     31.3
Expected option life
     3.12 years       3.25 years  
The company grants restricted stock units (RSUs) to directors, officers and employees under the terms of the 2018 Omnibus Incentive Plan, which vest ratably over three and five year periods. The current units are expensed straight-line over the remaining weighted-average period of 4.32 years. On November 30, 2021 there was $6,501,000 in unamortized compensation cost related to
non-vested
RSUs.
 
 
  
 
 
  
Weighted-
 
 
  
 
 
  
Average
 
(Options in thousands)
  
Shares
 
  
Fair Value
 
RSUs outstanding June 1, 2021
     121      $ 34.21  
Granted
     120        40.92  
Released
     (25      34.24  
Forfeited
     (3      34.49  
    
 
 
          
RSUs outstanding November 30, 2021
     213      $ 37.97  
The Company offers eligible employees the option to purchase common stock at a 5% discount to the lower of the market value of the stock at the beginning or end of each participation period under the terms of either the 2011 or the 2021 Employee Stock Purchase Plan; the discount is recorded in general and administrative expense. Total individual purchases in any year are limited to 10% of compensation.